JPS5822040B2 - Method for producing homopyriimidazole derivatives - Google Patents

Method for producing homopyriimidazole derivatives

Info

Publication number
JPS5822040B2
JPS5822040B2 JP50122508A JP12250875A JPS5822040B2 JP S5822040 B2 JPS5822040 B2 JP S5822040B2 JP 50122508 A JP50122508 A JP 50122508A JP 12250875 A JP12250875 A JP 12250875A JP S5822040 B2 JPS5822040 B2 JP S5822040B2
Authority
JP
Japan
Prior art keywords
formula
oxo
compound
producing
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP50122508A
Other languages
Japanese (ja)
Other versions
JPS5248692A (en
Inventor
初則 豊福
公一 橘
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wakamoto Pharmaceutical Co Ltd
Original Assignee
Wakamoto Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakamoto Pharmaceutical Co Ltd filed Critical Wakamoto Pharmaceutical Co Ltd
Priority to JP50122508A priority Critical patent/JPS5822040B2/en
Publication of JPS5248692A publication Critical patent/JPS5248692A/en
Publication of JPS5822040B2 publication Critical patent/JPS5822040B2/en
Expired legal-status Critical Current

Links

Description

【発明の詳細な説明】 本発明はホモピリイミダゾール誘導体の製造法に関し、
更に詳しくは式(1) で示される3−カルバモイル−4−オキソ−6−メチル
−6,7,8,9−テトラヒドロホモピリイミダゾール
の新規製造法に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing homopyriimidazole derivatives,
More specifically, the present invention relates to a new method for producing 3-carbamoyl-4-oxo-6-methyl-6,7,8,9-tetrahydrohomopyrimidazole represented by formula (1).

本発明により製造される式(1)の化合物はそれ自体麻
酔増力作用、解熱作用および鎮痛作用を有し医薬品とし
て有用であると共に、類縁の医薬品製造のための中間体
としても有用である。
The compound of formula (1) produced by the present invention itself has anesthetic-enhancing, antipyretic, and analgesic effects and is useful as a pharmaceutical, as well as an intermediate for producing related pharmaceuticals.

従来(1)式化合物の製造法としては、α、α′−ピコ
リルアミノメチレンマロン酸ジエチルエステルを多量の
オキシ塩化リンと少量のポIJ IJン酸共存下閉環さ
せて、3−カルボエトキシ−4−オキソ−6−メチルホ
モピリイミダゾールを得(特公昭49−39278号公
報参照)、次いでこの化合物を還元して3−カルボエト
キシ−4−オキソ−6−メチル−6,7,8,9−テト
ラヒドロホモピリイミダゾールを得(特公昭46−43
390号公報参照)、最後にこのカルボン酸エステルを
濃アンモニア水中に長時間放置してアミド化して式(1
)の3−カルバモイル−4−オキソ−6−メチルホモピ
リイミダゾールを得る方法(特公昭49−39278号
公報参照)が知られている。
The conventional method for producing the compound of formula (1) is to ring-close α,α'-picolyl aminomethylene malonic acid diethyl ester in the coexistence of a large amount of phosphorus oxychloride and a small amount of polyphosphoric acid to form 3-carboethoxy- 4-oxo-6-methylhomopyrimidazole was obtained (see Japanese Patent Publication No. 49-39278), and this compound was then reduced to give 3-carboethoxy-4-oxo-6-methyl-6,7,8,9 - Obtained tetrahydrohomopyrimidazole (Special Publication No. 46-43
(Refer to Publication No. 390), and finally, this carboxylic acid ester is left in concentrated ammonia water for a long time to amidate to give the formula (1
) is known (see Japanese Patent Publication No. 49-39278).

本発明者等は式(1)化合物の工業的有利な製造法を開
発すべく、種々研究を重ねた結果、式(3)で示される
α、α′−ピコリルアミノメチレンマロンニド、 IJ
ルをポIJ IJン酸共存下加熱反応させれば、式(2
) で示される3−カルバモイル−4−オキソ−6一メチル
ホモピリイミダゾールを高収率で生成し、この化合物は
通常の接触還元で容易に式(1)で示される3−カルバ
モイル−4−オキソ−6−メチル−6,7,8,9−テ
トラヒドロホモピリイミダゾールに変換し得ることを発
明した。
The present inventors have conducted various studies in order to develop an industrially advantageous manufacturing method for the compound of formula (1), and as a result, α,α'-picolyl amino methylene malonide, IJ, represented by formula (3)
If a heating reaction is carried out in the coexistence of poly-IJ-IJ-acid, the formula (2
) 3-carbamoyl-4-oxo-6-methylhomopyrimidazole represented by formula (1) is produced in high yield, and this compound is easily converted into 3-carbamoyl-4-oxo represented by formula (1) by ordinary catalytic reduction. -6-Methyl-6,7,8,9-tetrahydrohomopyrimidazole.

本発明によれば、従来の閉環、還元2よびアミド化の3
工程よりなる方法を加熱および還元の2工程に短縮して
式(1)の目的化合物を有利に製造し得る。
According to the present invention, conventional ring closure, reduction 2 and amidation 3
The target compound of formula (1) can be advantageously produced by shortening a method consisting of steps to two steps of heating and reduction.

次に本発明実施の態様を以下に詳細に説明する。Next, embodiments of the present invention will be described in detail below.

本発明に於いて出発原料として使用する式(3)のα−
α′−ヒコリルアミノメチレンマロンニトリルは文献未
載の新規化合物であるが、2−アミノピコリント低級ア
ルコキシメチレンマロンニトリルとを無溶媒又は不活性
溶媒中で反応させて好収率で高純度品を得ることが出来
る。
α- of formula (3) used as a starting material in the present invention
α'-Hycolylaminomethylenemalononitrile is a new compound that has not been described in any literature, but it can be produced with high purity in good yield by reacting it with 2-aminopicolinth lower alkoxymethylenemalonnitrile without a solvent or in an inert solvent. can be obtained.

式(3)の出発原料化合物をポIJ IJン酸中に加え
、約100℃乃至140℃程度の温度で溶解する迄攪拌
すれば反応はほぼ完結して、式(2)の3−カルバモイ
ル−4−オキソ−6−メチルホモポリイミダゾールが高
収率で生成する。
The reaction is almost completed by adding the starting material compound of formula (3) into polyhydric acid and stirring at a temperature of about 100°C to 140°C until it dissolves, and the 3-carbamoyl- of formula (2) is added. 4-oxo-6-methyl homopolyimidazole is produced in high yield.

なお、この加熱反応で直ちに前記(2)式化合物が生成
することを説明するための反応メカニズムは正確には不
明であるが、多分3−シアノ−4−イミノ−6−メチル
ホモピリイミダゾールが始めに生成し、これが同一反応
系に共存するポIJ IJン酸により直ちに加水分解さ
れることによるものと推定される。
The exact reaction mechanism that explains the immediate formation of the compound of formula (2) in this heating reaction is unclear, but it is likely that 3-cyano-4-imino-6-methylhomopyrimidazole is the starting material. This is presumed to be due to the fact that this is immediately hydrolyzed by the poly-IJ acid coexisting in the same reaction system.

反応物を室温迄冷却し、約10乃至40倍量の水に移し
、不溶物をP別後アルカリを加えてF液を弱アルカリ性
にし析出する結晶を戸数水洗し、適当な溶媒例えばメタ
ノール、エタノール等で再。
The reaction product was cooled to room temperature, transferred to about 10 to 40 times the amount of water, and after removing insoluble matter from P, alkali was added to make solution F weakly alkaline. etc. Re.

結晶することにより高純度の式(2)の化合物を得る。A highly pure compound of formula (2) is obtained by crystallization.

式(2)の化合物より式け)の3−カルバモイル−4−
オキソ−6−メチル−6,7,8,9−テトラヒドロホ
モピリイミダゾールを得るための還元工程は通常の接触
水添法で行なうことが出来る。
3-carbamoyl-4- from the compound of formula (2)
The reduction step for obtaining oxo-6-methyl-6,7,8,9-tetrahydrohomopyrimidazole can be carried out by a conventional catalytic hydrogenation method.

・例えば、低級アルコール溶媒中無機または有機の
酸の存在下パラジウム活性炭を用いて常圧上室温で好適
に目的の式けYヒ合物を得ることが出来る。
- For example, the desired compound of the formula Y can be suitably obtained using palladium activated carbon in the presence of an inorganic or organic acid in a lower alcohol solvent at normal pressure or room temperature.

なお、式(1)の化合物は無機酸の存在下加水分解して
相当するカルボン酸にするこさが出来所望によりこれを
エステル化することも出来る。
The compound of formula (1) can be hydrolyzed in the presence of an inorganic acid to give the corresponding carboxylic acid, which can also be esterified if desired.

以下、参考例および実施例を示して本発明を更に詳細に
説明する。
Hereinafter, the present invention will be explained in more detail by showing reference examples and examples.

参考例 1 2−アミノピコリン10.8gとエトキシメチレンマロ
ンニトリル12.2.9とを油浴上100℃で15分間
加熱攪拌する。
Reference Example 1 10.8 g of 2-aminopicoline and 12.2.9 g of ethoxymethylenemalonitrile are heated and stirred on an oil bath at 100° C. for 15 minutes.

反応物を冷却後エタノールと水から再結晶するとα、α
′−・ピコリルアミノメチレンマロンニトリル17.2
gをiる。
When the reactant is cooled and recrystallized from ethanol and water, α, α
'-Picolyl aminomethylene malonitrile 17.2
g to i.

収率 94.5% 融点 186.0〜186.5℃ Cl0H3N4としての元素分析値 C% N% N/16 計算値 65.20 4.38 30.42実測値
65.36 4.67 30.32実施例 1 ポIJ IJン酸(和光紬薬工業会社製品)10gを油
浴上140℃に加熱し、これにα、α′−ピコリルアミ
ノメチレンマロンニトリル460〜を添加し40分間攪
拌する。
Yield 94.5% Melting point 186.0-186.5℃ Elemental analysis value as Cl0H3N4 C% N% N/16 Calculated value 65.20 4.38 30.42 Actual value 65.36 4.67 30.32 Example 1 10 g of poly-IJ IJ acid (manufactured by Wako Tsumugi Kogyo Co., Ltd.) was heated to 140°C on an oil bath, and 460 ~ of α,α'-picolilaminomethylenemalonitrile was added thereto and stirred for 40 minutes.

反応後冷却し、水50TLlに溶解して不溶物を沢去後
、炭酸水素ナトリウムを添加してr液をアルカリ性にし
、水20m1を追加して冷所に一夜放置する。
After the reaction, the mixture is cooled, dissolved in 50 TL of water to remove insoluble matter, sodium bicarbonate is added to make the r solution alkaline, 20 ml of water is added, and the mixture is left in a cool place overnight.

析出した結晶を戸数水洗後メタノールと水から再結晶す
ると3−カルバモイル−4−オキソ−6−メチルホモピ
リイミダゾール288yn&を得る。
The precipitated crystals were washed several times with water and then recrystallized from methanol and water to obtain 3-carbamoyl-4-oxo-6-methylhomopyrimidazole 288yn&.

収率 56,0% 融点 263〜264°G C1oH302N3としての元素分析値 C% N% N% 計算値 59.10 4.46 20.68実測値
59.28 4.75 20.89実施例 2 3−カルツマモイル−4−オキソ−6−1+ルホモピリ
イミダゾール1.42.9をメタノール50m1中に懸
濁し、濃塩酸2mlと5%パラジウム活性炭5001n
9を加え、これに水素ガスを室温、大気圧で2時間導入
した後、不溶物を戸去し、F液を減圧上蒸発乾固し、残
査に水30m1を加えて溶解し、これに炭酸水素ナトリ
ウムを加えてアルカリ性にして析出する結晶をr去後、
涙液に酢酸エチルエステルを加えて抽出し、有機層を硫
酸マグネシウムで乾燥し、乾燥剤をr去後減圧下蒸発乾
固して得られる残置を採取し、これをエタノールから再
結晶すると3−カルバモイル−4−オキソ−6−メチル
−6,7,8,9−テトラヒドロホモピリイミダゾール
435ηを得る。
Yield 56.0% Melting point 263-264°G Elemental analysis value as C1oH302N3 C% N% N% Calculated value 59.10 4.46 20.68 Actual value 59.28 4.75 20.89 Example 2 3 - Caltumamoyl-4-oxo-6-1 + 1.42.9 ruhomopyrimidazole was suspended in 50 ml of methanol, 2 ml of concentrated hydrochloric acid and 5001 n of 5% palladium on activated carbon.
After introducing hydrogen gas at room temperature and atmospheric pressure for 2 hours, the insoluble matter was removed, and the F solution was evaporated to dryness under reduced pressure. 30 ml of water was added to the residue to dissolve it. After adding sodium hydrogen carbonate to make it alkaline and removing the precipitated crystals,
Ethyl acetate is added to the tear fluid for extraction, the organic layer is dried over magnesium sulfate, the desiccant is removed, the residue is evaporated to dryness under reduced pressure, and this is recrystallized from ethanol to obtain 3- Carbamoyl-4-oxo-6-methyl-6,7,8,9-tetrahydrohomopyrimidazole 435η is obtained.

収率 30.0% 融点 192〜193°C C1oH1302N3としての元素分析値C% H
% N% 計算値 57.96 6.32 20.08実測
値 58.09 6.32 19.88参考例
2 実施例2で得た化合物2.07gを水100m1と濃塩
酸50TLlの混液に溶解し、1時間30分加熱還流後
5%水酸化す) IJウムでpH約3に調整し、冷却放
置する。
Yield 30.0% Melting point 192-193°C Elemental analysis value as C1oH1302N3 C% H
% N% Calculated value 57.96 6.32 20.08 Actual value 58.09 6.32 19.88 Reference example
2 Dissolve 2.07 g of the compound obtained in Example 2 in a mixture of 100 ml of water and 50 TL of concentrated hydrochloric acid, heat under reflux for 1 hour and 30 minutes, then 5% hydroxide) Adjust the pH to about 3 with IJum and leave to cool. .

析出する結晶を戸数水洗後ベンゼンから再結晶すると、
4−オキソ−6−メチル−6,7,8,9−テトラヒド
ロホモピリイミダゾール−3−カルボン酸3.30gを
得る。
When the precipitated crystals are washed several times with water and then recrystallized from benzene,
3.30 g of 4-oxo-6-methyl-6,7,8,9-tetrahydrohomopyrimidazole-3-carboxylic acid are obtained.

収率 72.1% 融点 142〜145°C Cl1! HI3 o3N2としての元素分析値C%
H% N% 計算値 57.68 5.8,1 13.45実
測値 57.57 5.95 13.61□ こ
のものは、メタノール中塩酸の存在下加熱還流すると容
易に高収率で相当するメチルエステルの3−カルボメト
キシ−4−オキソ−6−メチル−6、7、8、9−テト
ラヒドロホモピリイミダゾールに変換出来る。
Yield 72.1% Melting point 142-145°C Cl1! Elemental analysis value C% as HI3 o3N2
H% N% Calculated value 57.68 5.8,1 13.45 Actual value 57.57 5.95 13.61□ This product easily corresponds in high yield when heated to reflux in the presence of hydrochloric acid in methanol. It can be converted to the methyl ester 3-carbomethoxy-4-oxo-6-methyl-6,7,8,9-tetrahydrohomopyrimidazole.

酢酸エチルエステルから再結晶すれば融点114℃を示
す。
When recrystallized from ethyl acetate, it has a melting point of 114°C.

Claims (1)

【特許請求の範囲】[Claims] 1 α、α′−ピコリルアミノメチレンマロンニトリル
をポIJ IJン酸共存下加熱反応させ、得られた3−
カルバモイル−4−オキソ−6−メチルホモピリイミダ
ゾールを還元することを特徴とする3゜−カルバモイル
−4−オキソ−6−メチル6.7,8゜9−テトラヒド
ロホモピリイミダゾールの製造法。
1 α, α′-Picolylaminomethylenemalononitrile was subjected to a heating reaction in the presence of polyacid, and the obtained 3-
A method for producing 3°-carbamoyl-4-oxo-6-methyl 6.7,8°9-tetrahydrohomopyrimidazole, which comprises reducing carbamoyl-4-oxo-6-methylhomopyrimidazole.
JP50122508A 1975-10-13 1975-10-13 Method for producing homopyriimidazole derivatives Expired JPS5822040B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP50122508A JPS5822040B2 (en) 1975-10-13 1975-10-13 Method for producing homopyriimidazole derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP50122508A JPS5822040B2 (en) 1975-10-13 1975-10-13 Method for producing homopyriimidazole derivatives

Publications (2)

Publication Number Publication Date
JPS5248692A JPS5248692A (en) 1977-04-18
JPS5822040B2 true JPS5822040B2 (en) 1983-05-06

Family

ID=14837573

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50122508A Expired JPS5822040B2 (en) 1975-10-13 1975-10-13 Method for producing homopyriimidazole derivatives

Country Status (1)

Country Link
JP (1) JPS5822040B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5996192U (en) * 1982-12-21 1984-06-29 積水プラントシステム株式会社 reinforced tank

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1209946A (en) * 1966-11-02 1970-10-21 Chinoin Gyogyszer Es Vegyeszet Homopyrimidazole derivatives
JPS4834897A (en) * 1971-09-10 1973-05-22
JPS4939278A (en) * 1972-08-21 1974-04-12

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1209946A (en) * 1966-11-02 1970-10-21 Chinoin Gyogyszer Es Vegyeszet Homopyrimidazole derivatives
JPS4834897A (en) * 1971-09-10 1973-05-22
JPS4939278A (en) * 1972-08-21 1974-04-12

Also Published As

Publication number Publication date
JPS5248692A (en) 1977-04-18

Similar Documents

Publication Publication Date Title
TWI653222B (en) Novel method for preparing prostaglandin guanamine (1)
HRP20000295A2 (en) Process for the preparation of a new finasteride
GB1563842A (en) Phenyl-acetic acids and derivatives thereof
JPWO2004067494A1 (en) Process for producing glutamic acid derivative and pyroglutamic acid derivative, and novel production intermediate
JPH0236595B2 (en)
US8809581B2 (en) Method of making 6-aminocaproic acid as active pharmaceutical ingredient
JP3440129B2 (en) Method for producing glutamine derivative
JPS5822040B2 (en) Method for producing homopyriimidazole derivatives
SU645549A3 (en) Method of obtaining 1,2-dioxycyclobutendion-3,4
WO2021020998A1 (en) Method for producing roxadustat
CN107935909B (en) Synthesis method of nintedanib and intermediate thereof
JPS6327337B2 (en)
JPH1129540A (en) Production of ester derivative
JP2815438B2 (en) Purification method of 1,2-bis (nicotinamide) propane
JPS5919545B2 (en) New tricyclic cage-shaped amine compound
JPH06340623A (en) Production of benzylsuccinic acid derivative and intermediate for its synthesis
JPH11512114A (en) Preparation of disubstituted thiazoles
KR100359503B1 (en) Method of preparing an aromatic propionic acid derivative
JP2016511761A (en) Method for synthesizing 4-piperidin-4-yl-benzene-1,3-diol and salts thereof, and novel compound tert-butyl 4- (2,4-dihydroxy-phenyl) -4-hydroxy-piperidine-1-carboxylate
JPH0129793B2 (en)
SU691083A3 (en) Method of producing derivatives of bis-(benamido)-benzol or salts thereof
JPS5915919B2 (en) Method for producing (N-methylpyryl-2)acetothioamide derivative
JPH072686B2 (en) Biphenyl derivative and method for producing the same
JPS607988B2 (en) Improved synthesis method of 3-amino-5-tert-butyl isoxazole
KR20200122826A (en) Process for Preparing Naldemedine